YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

AstraZeneca buys Almirall lung drugs for up to $2.1B

Posted online
AstraZeneca took a major step to build up its respiratory medicine business on Wednesday by striking a deal worth up to $2.1 billion for the rights to Spanish group Almirall's lung drugs.

The British drugmaker, which in May resisted a $118 billion takeover attempt by Pfizer, agreed to pay Almirall $875 million up front and up to $1.22 billion if the the drugs meet development and sales targets, according to Fox Business.

According to the article, the deal is a notable win for Almirall, giving it extra funding to increase its focus on dermatology.

Read more from Fox Business.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Annual downtown holiday events combine for Nov. 21 celebration

Organizers hope to bolster client traffic to center city businesses.

Most Read
SBJ.net Poll
How often do you use artificial intelligence for your business?

*

View results

Update cookies preferences